Lv21
134 积分 2021-10-18 加入
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castrationsensitive prostate cancer (PEACE-1): a multicentre, openlabel, randomised, phase 3 study with a 2×2 factorial design
9小时前
已完结
Prostate Cancer–related Events in Patients with Synchronous Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate; Data from the HORRAD Trial
3个月前
已完结
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
3个月前
已完结
Based on ARASENS trial: efficacy and safety of darolutamide as an emerging option of endocrinotherapy for metastatic hormone-sensitive prostate cancer—an updated systematic review and network meta-analysis
6个月前
已完结
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis
6个月前
已完结
Prognostic importance of concomitant non-regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer
6个月前
已完结
Cytoreductive Radical Prostatectomy in Patients with Prostate Cancer and Low Volume Skeletal Metastases: Results of a Feasibility and Case-Control Study
8个月前
已完结
Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease
8个月前
已完结
Changing Nature of High Risk Patients Undergoing Radical Prostatectomy
10个月前
已完结
Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents
10个月前
已完结
皖公网安备34019202002308
